Free Trial

Bristol-Myers Squibb (BMY) Earnings Date, Estimates & Call Transcripts

Bristol-Myers Squibb logo
$57.88 -0.35 (-0.60%)
(As of 11/20/2024 ET)

Bristol-Myers Squibb Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 7Estimated
Actual EPS
(Oct. 31)
$1.80 Beat By $0.31
Consensus EPS
(Oct. 31)
$1.49

Bristol-Myers Squibb posted Q3 2024 earnings on October 31, 2024, reporting an EPS of $1.80, which topped analysts' consensus estimates of $1.49 by $0.31. Quarterly revenue rose 8.4% year-over-year to $11.89 billion, above analyst estimates of $11.26 billion. With a trailing EPS of -$3.59, Bristol-Myers Squibb's earnings are expected to grow 667.74% next year, from $0.93 to $7.14 per share.

BMY Upcoming Earnings

Bristol-Myers Squibb's next earnings date is estimated for Friday, February 7, 2025, based off prior year's reporting schedules.

Get Bristol-Myers Squibb Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bristol-Myers Squibb and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Bristol-Myers Squibb Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$1.51$2.07$1.72 
Q2 20244$1.63$2.00$1.75 
Q3 20244$1.51$1.91$1.64 
Q4 20244$1.41$1.84$1.53 
FY 202416$6.06$7.82$6.64 
Q1 20252$1.75$1.83$1.79 
Q2 20252$1.92$1.92$1.92 
Q3 20252$1.72$2.04$1.88 
Q4 20252$1.60$1.80$1.70 
FY 20258$6.99$7.59$7.29 
Q1 20261$1.47$1.47$1.47 
Q2 20261$1.69$1.69$1.69 
Q3 20261$1.57$1.57$1.57 

Bristol-Myers Squibb Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/7/2025
(Estimated)
------- 
10/31/2024Q3 2024$1.49$1.80+$0.31$3.00$11.26B$11.89B        
7/26/2024Q2 2024$1.64$2.07+$0.43$3.31$11.54B$12.20B          
4/25/2024Q1 2024-$4.53-$4.40+$0.13$9.69$11.45B$11.87B          
2/2/2024Q4 2023$1.55$1.70+$0.15$2.53$11.19B$11.48B        
10/26/2023Q3 2023$1.76$2.00+$0.24$3.07$10.96B$10.97B          
7/27/2023Q2 2023$1.99$1.75 -$0.24$2.51$11.81B$11.23B        
4/27/2023Q1 2023$1.98$2.05+$0.07$3.03$11.50B$11.34B        
2/2/2023Q4 2022$1.71$1.82+$0.11$2.69$11.20B$11.41B        

Bristol-Myers Squibb Earnings - Frequently Asked Questions

Bristol-Myers Squibb has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, February 7th, 2025 based off last year's report dates. Learn more on BMY's earnings history.

Bristol-Myers Squibb issued an update on its FY 2024 earnings guidance on Thursday, October, 31st. The company provided earnings per share (EPS) guidance of 0.750-0.950 for the period, compared to the consensus estimate of 0.710. The company issued revenue guidance of $47.3 billion-$47.3 billion, compared to the consensus revenue estimate of $46.8 billion.

In the previous quarter, Bristol-Myers Squibb (NYSE:BMY) reported $1.80 earnings per share (EPS) to beat the analysts' consensus estimate of $1.49 by $0.31. Learn more on analysts' earnings estimate vs. BMY's actual earnings.

The conference call for Bristol-Myers Squibb's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Bristol-Myers Squibb's latest earnings report can be read online.
Read Transcript

Bristol-Myers Squibb (NYSE:BMY) has a recorded annual revenue of $47.44 billion.

Bristol-Myers Squibb (NYSE:BMY) has a recorded net income of $8.03 billion. BMY has generated -$3.59 earnings per share over the last four quarters.

Bristol-Myers Squibb (NYSE:BMY) has a forward price-to-earnings ratio of 62.24. The price/earnings-to-growth ratio is 15.08.

Bristol-Myers Squibb's earnings are expected to grow from $0.93 per share to $7.14 per share in the next year, which is a 667.74% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:BMY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners